Übersicht der SEO Analyse
Metaangaben
80% 
Seitenqualität
74% 
Seitenstruktur
100% 
Verlinkung
26% 
Server
100% 
Externe Faktoren
100% 
SEO Score
Antwortzeit
0,38 s
Dateigröße
203,20 kB
Wörter
1246
Medien
22
Anzahl Links
341 Intern / 12 Extern

To-do Liste mit SEO Optimierungen

Meta-Angaben im HTML

Titel
(Extrem wichtig)
Novartis
Der Titel ist zu kurz. (73 Pixel von maximal 580 Pixel Länge) Jetzt optimieren
Der Seitentitel besteht nur aus einem Wort.
Es gibt keine Wortwiederholungen im Titel.
Meta-Description
(Extrem wichtig)
Working together, we can reimagine medicine to improve and extend people’s lives.
Die Meta-Description hat eine optimale Länge. (512 Pixel von maximal 1000 Pixel Länge)
Crawlbarkeit
(Extrem wichtig)
Es gibt keine Probleme beim Zugriff auf die Webseite.
Canonical Link
(Wichtig)
https://www.novartis.com/
Die Seite hat einen korrekten Canonical Link.
Sprache
(Wenig wichtig)
Im Text erkannte Sprache: en
Im HTML angegebene Sprache: en
Serverstandort: Kanada
Die Sprache wird im HTML Code wie folgt angegeben: en
Alternate/Hreflang Links
(Wenig wichtig)
Die angegebenen Alternate Links sind fehlerfrei.
Weitere Metatags
(Wenig wichtig)
Es gibt keinen rel next Meta Tag auf der Seite.
Es gibt keinen rel prev Meta Tag auf der Seite.
Domain
(Wenig wichtig)
Die Domain ist keine Subdomain.
Die Länge der Domain ist gut.
Die Domain enthält keine Umlaute.
Seiten URL
(Wenig wichtig)
In der URL wurden keine Parameter entdeckt.
In der URL wurde keine Session ID entdeckt.
Die URL hat nicht zu viele Unterverzeichnisse.
Zeichensatzkodierung
(Wenig wichtig)
Die Angaben zur Zeichensatzkodierung (UTF-8) sind fehlerfrei.
Doctype
(Nice to have)
Die Doctype Angabe HTML 5 ist korrekt angegeben.
Die Doctype Angabe befindet sich an erster Stelle im HTML-Code.
Favicon
(Nice to have)
Das Favoriten Icon (Favicon) ist korrekt verlinkt.

Meta Tags

NameWert
descriptionWorking together, we can reimagine medicine to improve and extend people’s lives.
abstractWorking together, we can reimagine medicine to improve and extend people’s lives.
google-site-verificationoWLifsm3cWEQxnH7h2q7auXVJgDapVcYDRjNg1rESi4
MobileOptimizedwidth
HandheldFriendlytrue
viewportwidth=device-width, initial-scale=1, shrink-to-fit=no
langen
twitter:cardsummary_large_image
twitter:site@novartis
twitter:descriptionWorking together, we can reimagine medicine to improve and extend people’s lives.
twitter:titleNovartis
twitter:site:id17226612
twitter:creator:id17226612
twitter:creator@novartis
twitter:urlhttps://www.novartis.com/home
twitter:imagehttps://www.novartis.com/sites/novartis_com/files/novartis-logo-open-graph.jpg
twitter:image:altNovartis logo
og:site_nameNovartis
og:typeWebsite
og:urlhttps://www.novartis.com/home
og:titleNovartis
og:descriptionWorking together, we can reimagine medicine to improve and extend people’s lives.
og:imagehttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
og:image:urlhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
og:image:secure_urlhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
og:image:altNovartis logo
x-ua-compatibleie=edge
charsetutf-8

Analysiere novartis.com jetzt automatisch und vollständig mit allen Unterseiten!

Jetzt kostenlos testen
Garantiert keine Kosten während der Testphase.

Seitenqualität

Inhalt
(Extrem wichtig)
Wörter aus der H1 Überschrift werden nicht im Text der Seite verwendet.
Der Inhalt ist mit 1246 Wörtern in Ordnung.
Der Text besteht zu 15.3% aus Füllwörtern.
Im Text befindet sich eine Aufzählung, dies deutet auf eine gute Textstruktur hin.
Es wurden 13 Fließtextblöcke auf der Seite gefunden.
Es wurden keine Platzhalter Texte bzw. Bilder gefunden.
Es befinden sich keine Duplikate auf der Seite.
Die durchschnittliche Satzlänge ist mit 13 Wörtern gut.
Frames
(Extrem wichtig)
Die Seite hat kein Frameset.
Mobile
(Wenig wichtig)
Es ist kein Apple-Touch Icon angegeben.
Der angegebene Viewport (width=device-width, initial-scale=1, shrink-to-fit=no) ist korrekt.
Bold- und Strongtags
(Wenig wichtig)
Die Menge an Tags ist mit 127 sehr hoch. Wir empfehlen für diese Webseite die Verwendung von maximal 25 Tags.
Einige Tags werden wiederholt. z.B.: international
Bilder Optimierung
(Wenig wichtig)
Alle gefundenen Bilder haben Alt-Attribute. (Alternativer Bild Text)
Soziale Vernetzung
(Nice to have)
Die Seite ist optimal auf Soziale Netzwerke ausgerichtet.
Zusätzliches Markup
(Nice to have)
Es wurde kein zusätzliches Markup gefunden.
HTTPS
(Wenig wichtig)
Die Seite verwendet HTTPS um Daten sicher zu übertragen.
Alle eingebundenen Dateien werden ebenfalls über HTTPS ausgeliefert.

Medienliste

URLALT-AttributeTitel
/themes/custom/polaris/logo.svgNovartisHome
.../polaris/patterns/images/icon-search.svgOpen
...m/polaris/patterns/images/icon-close.svgClose
...custom/polaris/patterns/images/globe.svglanguage-selector-globe
...custom/polaris/patterns/images/globe.svglanguage-selector-globe
...bed-kid-room-menu.jpg.webp?itok=6RZr5Lb7Mother and daughter cuddling on a bed in a kids roomMother and daughter cuddling on a bed in a kids room
...ench-in-park-menu.jpg.webp?itok=C15Fc3fFAdult daughter talking to her senior parents on a bench in a parkAdult daughter talking to her senior parents on a bench in a park
...patient-in-office.jpg.webp?itok=HtKzFn-pDoctor discussing illness with patient in an officeDoctor discussing illness with patient in an office
...ientist-cambridge.jpg.webp?itok=nAcv-yKNA female research scientist in a lab looking at a sampleA female research scientist in a lab looking at a sample
...nds-party-at-home.jpg.webp?itok=FS12EXewFamily and friends having a party at homeFamily and friends having a party at home
...ptop-on-sofa-menu.jpg.webp?itok=bH-X-V18Business woman working on her laptop in a bright atmosphereBusiness woman working on her laptop in a bright atmosphere
...11/news-hero-menu.jpg.webp?itok=OeYNijgYOverhead view of a meeting room with people in the foreground and screens in the backgroundOverhead view of a meeting room with people in the foreground and screens in the background
...-people-mega-menu.jpg.webp?itok=dz36nQMYTwo business peopleTwo business people
...ing-on-beach-menu.jpg.webp?itok=18W4Jg_tGrandmother, mother and daughter smiling and laughing on a beachGrandmother, mother and daughter smiling and laughing on a beach
...0r0wz0d1/version/100001.jpg/height/674pxscientist-looking-at-a-screen
...hess-and-laughing.jpg.webp?itok=4ubTg8y7Two men, seated indoors around a table, engaged in a conversation and playing chessTwo men, seated indoors around a table, engaged in a conversation and playing chess
...ientist-cambridge.jpg.webp?itok=GLon0edOA female research scientist in a lab looking at a sampleA female research scientist in a lab looking at a sample
...ling-and-laughing.jpg.webp?itok=VK291-kxGroup of warm clothed women, seated outside, smiling and laughingGroup of warm clothed women, seated outside, smiling and laughing
...025-media-content.jpg.webp?itok=buTgDVrfQ2 2025Q2 2025
...rch-lab-Cambridge.jpg.webp?itok=AR-v2AfMHigh resolution picture of an artificial heart muscle from a research lab in Cambridge.High resolution picture of an artificial heart muscle from a research lab in Cambridge.
...-laughing-in-body.jpg.webp?itok=hG3uYA-HThree business people laughingThree business people laughing
...-and-her-labrador.jpg.webp?itok=4HIqaVLdKate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, FloridaKate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida

Seitenstruktur

H1 Überschrift
(Extrem wichtig)
Reimagining medicine, together
Die H1-Überschrift ist perfekt.
Überschriften
(Wichtig)
Die Überschriftenstruktur ist fehlerfrei.

Überschriftenstruktur

Überschriften HierarchieInhalt
H1 Reimagining medicine, together
H2 Novartis Financial Results – Q2 2025
H2 Latest news
H2 Live. Magazine
H2 Welcome to where we thrive together
H2 Novartis in Society Integrated Report 2024
H2 Resource links
H2 Novartis
H3 Discover our medicines
H3 Explore our science
H3 Learn about our impact
H3 Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the company
H3 Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
H3 Novartis receives approval for first malaria medicine for newborn babies and young infants
Einige der Linktexte der internen Links sind zu lang.
Einige der Linktexte wiederholen sich.
Die Anzahl an internen Links ist ok.
Alle internen Links haben keine dynamischen Parameter.
Es befinden sich 12 externe Links auf der Seite.
LinkAttributeLinktext
https://www.novartis.com/Anchor Skip to main content
https://www.novartis.com/IMG-ALT Novartis
https://www.novartis.com/Anchor International
https://www.novartis.com/Anchor Americas
https://www.novartis.com/Anchor Asia Pacific
https://www.novartis.com/Anchor Europe
https://www.novartis.com/Anchor Middle East & Africa
https://www.novartis.com/Subdomain Global | English
https://www.novartisfoundation...Extern Subdomain Novartis Foundation | English
https://www.novartis.com/ar-es/Subdomain Argentina | Español
https://www.novartis.com/br-pt/Subdomain Brazil | Português
https://www.novartis.com/ca-en/Subdomain Canada | English
https://www.novartis.com/ca-fr/Subdomain Canada | Français
/candean-es/Subdomain Central America | Español
https://www.novartis.com/co-es/Subdomain Colombia | Español
https://www.novartis.com/mx-es/Subdomain Mexico | Español
https://www.novartis.com/us-en/Subdomain United States | English
https://www.novartis.com/au-en/Subdomain Australia | English
https://www.novartis.com/hk-zh/Subdomain Hong Kong S.A.R. | 繁體中文
https://www.novartis.com/in-en/Subdomain India | English
https://www.novartis.com/id-en/Subdomain Indonesia | English
https://www.novartis.com/jp-ja/Subdomain Japan | 日本語
https://www.novartis.com/kr-ko/Subdomain Korea | 한국어
https://www.novartis.com.cn/Extern Subdomain Mainland China | 中文
https://www.novartis.com/my-en/Subdomain Malaysia | English
https://www.novartis.com/pk-en/Subdomain Pakistan | English
https://www.novartis.com/ph-en/Subdomain Philippines | English
https://www.novartis.com/sg-en/Subdomain Singapore | English
https://www.novartis.com/tw-zh/Subdomain Taiwan | 繁體中文
https://www.novartis.com/th-th/Subdomain Thailand | ภาษาไทย
https://www.novartis.com/at-de/Subdomain Austria | Deutsch
https://www.novartis.com/be-fr/Subdomain Belgium | Français
https://www.novartis.com/be-nl/Subdomain Belgium | Nederlands
https://www.novartis.com/bg-bg/Subdomain Bulgaria | Български
https://www.novartis.com/cz-cs/Subdomain Czech Republic | Česky
https://www.novartis.com/cz-en/Subdomain Czech Republic | English
https://www.novartis.com/dk-da/Subdomain Denmark | Dansk
https://www.novartis.com/ee-et/Subdomain Estonia | Eesti
https://www.novartis.com/fi-fi/Subdomain Finland | Suomalainen
https://www.novartis.com/fr-fr/Subdomain France | Français
https://www.novartis.com/de-de/Subdomain Germany | Deutsch
https://www.novartis.com/gr-el/Subdomain Greece | Ελληνικά
https://www.novartis.com/hu-hu/Subdomain Hungary | Magyar
https://www.novartis.com/ie-en/Subdomain Ireland | English
https://www.novartis.com/it-it/Subdomain Italy | Italiano
https://www.novartis.com/lv-lv/Subdomain Latvia | Latvian
https://www.novartis.com/lt-lt/Subdomain Lithuania | Lithuanian
https://www.novartis.com/nl-nl/Subdomain Netherlands | Nederlands
https://www.novartis.com/no-no/Subdomain Norway | Norsk
https://www.novartis.com/pl-pl/Subdomain Poland | Polski
https://www.novartis.com/pt-pt/Subdomain Portugal | Português
https://www.novartis.com/ro-ro/Subdomain Romania | Română
https://www.novartis.com/ru-ru/Subdomain Russia | Русский
https://www.novartis.com/rs-sr/Subdomain Serbia | Srpski
https://www.novartis.com/sk-sk/Subdomain Slovakia | Slovensky
https://www.novartis.com/si-sl/Subdomain Slovenia | Slovenščina
https://www.novartis.com/si-en/Subdomain Slovenia | English
https://www.novartis.com/es-es/Subdomain Spain | Español
https://www.novartis.com/se-se/Subdomain Sweden | Svenska
https://www.novartis.com/ch-de/Subdomain Switzerland | Deutsch
https://www.novartis.com/ch-fr/Subdomain Switzerland | Français
https://www.novartis.com/tr-tr/Subdomain Türkiye | Türkçe
https://www.novartis.com/uk-en/Subdomain United Kingdom | English
https://www.novartis.com/eg-en/Subdomain Egypt | English
https://www.novartis.com/il-he/Subdomain Israel | עברית
https://www.novartis.com/sa-ar/Subdomain Saudi Arabia | العربية
https://www.novartis.com/za-en/Subdomain South Africa | English
https://www.novartis.com/Anchor Textduplikat International
https://www.novartis.com/Anchor Textduplikat Americas
https://www.novartis.com/Anchor Textduplikat Asia Pacific
https://www.novartis.com/Anchor Textduplikat Europe
https://www.novartis.com/Anchor Textduplikat Middle East & Africa
https://www.novartis.com/ar-es/Subdomain Textduplikat Argentina | Español
https://www.novartis.com/au-en/Subdomain Textduplikat Australia | English
https://www.novartis.com/at-de/Subdomain Textduplikat Austria | Deutsch
https://www.novartis.com/be-fr/Subdomain Textduplikat Belgium | Français
https://www.novartis.com/be-nl/Subdomain Textduplikat Belgium | Nederlands
https://www.novartis.com/br-pt/Subdomain Textduplikat Brazil | Português
https://www.novartis.com/bg-bg/Subdomain Textduplikat Bulgaria | Български
https://www.novartis.com/ca-en/Subdomain Textduplikat Canada | English
https://www.novartis.com/ca-fr/Subdomain Textduplikat Canada | Français
/candean-es/Subdomain Textduplikat Central America | Español
https://www.novartis.com/co-es/Subdomain Textduplikat Colombia | Español
https://www.novartis.com/cz-cs/Subdomain Textduplikat Czech Republic | Česky
https://www.novartis.com/cz-en/Subdomain Textduplikat Czech Republic | English
https://www.novartis.com/dk-da/Subdomain Textduplikat Denmark | Dansk
https://www.novartis.com/eg-en/Subdomain Textduplikat Egypt | English
https://www.novartis.com/ee-et/Subdomain Textduplikat Estonia | Eesti
https://www.novartis.com/fi-fi/Subdomain Textduplikat Finland | Suomalainen
https://www.novartis.com/fr-fr/Subdomain Textduplikat France | Français
https://www.novartis.com/de-de/Subdomain Textduplikat Germany | Deutsch
https://www.novartis.com/gr-el/Subdomain Textduplikat Greece | Ελληνικά
https://www.novartis.com/hk-zh/Subdomain Textduplikat Hong Kong S.A.R. | 繁體中文
https://www.novartis.com/hu-hu/Subdomain Textduplikat Hungary | Magyar
https://www.novartis.com/in-en/Subdomain Textduplikat India | English
https://www.novartis.com/id-en/Subdomain Textduplikat Indonesia | English
https://www.novartis.com/ie-en/Subdomain Textduplikat Ireland | English
https://www.novartis.com/il-he/Subdomain Textduplikat Israel | עברית
https://www.novartis.com/it-it/Subdomain Textduplikat Italy | Italiano
https://www.novartis.com/jp-ja/Subdomain Textduplikat Japan | 日本語
https://www.novartis.com/kr-ko/Subdomain Textduplikat Korea | 한국어
https://www.novartis.com/lv-lv/Subdomain Textduplikat Latvia | Latvian
https://www.novartis.com/lt-lt/Subdomain Textduplikat Lithuania | Lithuanian
https://www.novartis.com.cn/Extern Subdomain Textduplikat Mainland China | 中文
https://www.novartis.com/my-en/Subdomain Textduplikat Malaysia | English
https://www.novartis.com/mx-es/Subdomain Textduplikat Mexico | Español
https://www.novartis.com/nl-nl/Subdomain Textduplikat Netherlands | Nederlands
https://www.novartis.com/no-no/Subdomain Textduplikat Norway | Norsk
https://www.novartis.com/Subdomain Textduplikat Global | English
https://www.novartisfoundation...Extern Subdomain Textduplikat Novartis Foundation | English
https://www.novartis.com/pk-en/Subdomain Textduplikat Pakistan | English
https://www.novartis.com/ph-en/Subdomain Textduplikat Philippines | English
https://www.novartis.com/pl-pl/Subdomain Textduplikat Poland | Polski
https://www.novartis.com/pt-pt/Subdomain Textduplikat Portugal | Português
https://www.novartis.com/ro-ro/Subdomain Textduplikat Romania | Română
https://www.novartis.com/ru-ru/Subdomain Textduplikat Russia | Русский
https://www.novartis.com/sa-ar/Subdomain Textduplikat Saudi Arabia | العربية
https://www.novartis.com/rs-sr/Subdomain Textduplikat Serbia | Srpski
https://www.novartis.com/sg-en/Subdomain Textduplikat Singapore | English
https://www.novartis.com/sk-sk/Subdomain Textduplikat Slovakia | Slovensky
https://www.novartis.com/si-sl/Subdomain Textduplikat Slovenia | Slovenščina
https://www.novartis.com/si-en/Subdomain Textduplikat Slovenia | English
https://www.novartis.com/za-en/Subdomain Textduplikat South Africa | English
https://www.novartis.com/es-es/Subdomain Textduplikat Spain | Español
https://www.novartis.com/se-se/Subdomain Textduplikat Sweden | Svenska
https://www.novartis.com/ch-de/Subdomain Textduplikat Switzerland | Deutsch
https://www.novartis.com/ch-fr/Subdomain Textduplikat Switzerland | Français
https://www.novartis.com/tw-zh/Subdomain Textduplikat Taiwan | 繁體中文
https://www.novartis.com/th-th/Subdomain Textduplikat Thailand | ภาษาไทย
https://www.novartis.com/tr-tr/Subdomain Textduplikat Türkiye | Türkçe
https://www.novartis.com/uk-en/Subdomain Textduplikat United Kingdom | English
https://www.novartis.com/us-en/Subdomain Textduplikat United States | English
https://www.novartis.com/aboutAbout
A-TITLE About
/about/board-directorsBoard of Directors
A-TITLE Board of Directors
/about/board-directors/giovann...Giovanni Caforio
A-TITLE Giovanni Caforio
/about/board-directors/simon-m...Simon Moroney
A-TITLE Simon Moroney
/about/board-directors/nancy-c...Nancy C. Andrews
A-TITLE Nancy C. Andrews
/about/board-directors/ton-bue...Ton Buechner
A-TITLE Ton Buechner
/about/board-directors/patrice...Patrice Bula
A-TITLE Patrice Bula
/about/board-directors/elizabe...Elizabeth (Liz) Doherty
A-TITLE Elizabeth (Liz) Doherty
/about/board-directors/ana-de-...Ana de Pro Gonzalo
A-TITLE Ana de Pro Gonzalo
/about/board-directors/bridget...Bridgette Heller
A-TITLE Bridgette Heller
/about/board-directors/daniel-...Daniel Hochstrasser
A-TITLE Daniel Hochstrasser
/about/board-directors/frans-v...Frans van Houten
A-TITLE Frans van Houten
/about/board-directors/elizabe...Elizabeth McNally
A-TITLE Elizabeth McNally
/about/board-directors/john-d-...John D. Young
A-TITLE John D. Young
/about/board-directors/charlot...Charlotte Pamer-Wieser
A-TITLE Charlotte Pamer-Wieser
/about/executive-committeeExecutive Committee
A-TITLE Executive Committee
/about/executive-committee/vas...Vasant (Vas) Narasimhan
A-TITLE Vasant (Vas) Narasimhan
/about/executive-committee/shr...Shreeram Aradhye
A-TITLE Shreeram Aradhye
/about/executive-committee/vic...Victor Bulto
A-TITLE Victor Bulto
/about/executive-committee/aha...Aharon (Ronny) Gal
A-TITLE Aharon (Ronny) Gal
/about/executive-committee/kar...Karen L. Hale
A-TITLE Karen L. Hale
/about/executive-committee/pat...Patrick Horber
A-TITLE Patrick Horber
/about/executive-committee/har...Harry Kirsch
A-TITLE Harry Kirsch
/about/executive-committee/rob...Rob Kowalski
A-TITLE Rob Kowalski
/about/executive-committee/ste...Steffen Lang
A-TITLE Steffen Lang
/about/executive-committee/fio...Fiona Marshall
A-TITLE Fiona Marshall
/about/executive-committee/lut...Lutz Hegemann
A-TITLE Lutz Hegemann
/about/executive-committee/ter...Teresa Jose
A-TITLE Teresa Jose
/about/executive-committee/mic...Michelle Weese
A-TITLE Michelle Weese
/about/productsProducts
A-TITLE Products
/about/therapeutic-areasTherapeutic areas
A-TITLE Therapeutic areas
/about/therapeutic-areas/cardi...Cardiovascular, renal and metabolic
A-TITLE Cardiovascular, renal and metabolic
/about/therapeutic-areas/immun...Immunology
A-TITLE Immunology
/about/therapeutic-areas/neuro...Neuroscience
A-TITLE Neuroscience
/about/therapeutic-areas/oncologyOncology
A-TITLE Oncology
/about/people-and-culturePeople and culture
A-TITLE People and culture
/about/inclusionInclusion
A-TITLE Inclusion
/about/inclusion/promoting-inc...Promoting inclusion
A-TITLE Promoting inclusion
/about/inclusion/building-belo...Building belonging
A-TITLE Building belonging
/about/inclusion/parental-leaveParental leave
A-TITLE Parental leave
/about/inclusion/caring-mental...Caring for the mental health and wellbeing of our people
A-TITLE Caring for the mental health and wellbeing of our people
/about/novartis-gene-therapiesNovartis Gene Therapies
A-TITLE Novartis Gene Therapies
/about/manufacturingManufacturing
A-TITLE Manufacturing
/about/qualityQuality
A-TITLE Quality
/about/quality/audit-programAudit program
A-TITLE Audit program
/about/quality/novartis-qualit...Novartis quality management system (QMS)
A-TITLE Novartis quality management system (QMS)
/about/quality/product-and-pat...Product and patient safety training
A-TITLE Product and patient safety training
/about/quality/regulatory-insp...Regulatory inspections
A-TITLE Regulatory inspections
/about/quality/product-recallsProduct recalls
A-TITLE Product recalls
/about/quality/third-party-sup...Third-party suppliers
A-TITLE Third-party suppliers
/about/novartis-and-european-u...Novartis and the European Union (EU)
A-TITLE Novartis and the European Union (EU)
/about/awards-and-recognitionAwards and recognition
A-TITLE Awards and recognition
/patients-and-caregiversPatients and caregivers
A-TITLE Patients and caregivers
/patients-and-caregivers/novar...Novartis commitment to patients and caregivers
A-TITLE Novartis commitment to patients and caregivers
https://www.novartis.com/diseasesDiseases
A-TITLE Diseases
/investors/reporting-and-trans...Patient organization funding
A-TITLE Patient organization funding
/news/stories/patient-perspect...Patients perspectives stories
A-TITLE Patients perspectives stories
/healthcare-professionalsHealthcare professionals
A-TITLE Healthcare professionals
/healthcare-professionals/medi...Medical congresses and events
A-TITLE Medical congresses and events
/healthcare-professionals/medi...ASCO Annual Meeting
A-TITLE ASCO Annual Meeting
/about/productsTextduplikat Products
A-TITLE Products
/research-development/novartis...Novartis pipeline
A-TITLE Novartis pipeline
/healthcare-professionals/mana...Managed access programs
A-TITLE Managed access programs
/healthcare-professionals/mana...Zolgensma® Global Managed Access Program (gMAP)
A-TITLE Zolgensma® Global Managed Access Program (gMAP)
/healthcare-professionals/nova...Novartis external funding
A-TITLE Novartis external funding
/healthcare-professionals/heal...Healthcare professional resources by country
A-TITLE Healthcare professional resources by country
/healthcare-professionals/inve...Investigator-initiated trials / studies
A-TITLE Investigator-initiated trials / studies
/healthcare-professionals/nova...Novartis medical information
A-TITLE Novartis medical information
/healthcare-professionals/nova...Submit medical enquiry
A-TITLE Submit medical enquiry
/research-and-developmentResearch and development
A-TITLE Research and development
/research-and-development/tech...Technology platforms
A-TITLE Technology platforms
/research-and-development/rese...Research disease areas
A-TITLE Research disease areas
/research-and-development/rese...Cardiovascular and metabolic disease research at Novartis
A-TITLE Cardiovascular and metabolic disease research at Novartis
/research-and-development/rese...DAx: exploratory disease research at Novartis
A-TITLE DAx: exploratory disease research at Novartis
/research-and-development/rese...Global Health disease area research at Novartis
A-TITLE Global Health disease area research at Novartis
/research-and-development/rese...Immunology disease research at Novartis
A-TITLE Immunology disease research at Novartis
/research-and-development/rese...Neuroscience research at Novartis
A-TITLE Neuroscience research at Novartis
/research-and-development/rese...Oncology research at Novartis
A-TITLE Oncology research at Novartis
/research-development/novartis...Textduplikat Novartis pipeline
A-TITLE Novartis pipeline
/research-and-development/rese...Research collaborations
A-TITLE Research collaborations
/research-and-development/coll...Collaborations
A-TITLE Collaborations
https://www.novartis.com/esgESG
A-TITLE ESG
/esg/accessAccess
A-TITLE Access
/esg/access/creating-sustainab...Creating sustainable business models
A-TITLE Creating sustainable business models
/esg/access/value-based-pricingValue-based pricing
A-TITLE Value-based pricing
/esg/access/sub-saharan-africaSub-Saharan Africa
A-TITLE Sub-Saharan Africa
/esg/access/donationsDonations
A-TITLE Donations
/esg/access/novartis-access-pr...Novartis access principles
A-TITLE Novartis access principles
/esg/access/novartis-oncology-...Novartis oncology access
A-TITLE Novartis oncology access
/esg/access/patents-and-licensingPatents and licensing
A-TITLE Patents and licensing
/esg/environmental-sustainabilityEnvironmental sustainability
A-TITLE Environmental sustainability
/esg/environmental-sustainabil...Climate
A-TITLE Climate
/esg/environmental-sustainabil...Nature - Waste
A-TITLE Nature - Waste
/esg/environmental-sustainabil...Nature - Water
A-TITLE Nature - Water
/esg/ethics-risk-and-complianceEthics, risk and compliance
A-TITLE Ethics, risk and compliance
/esg/ethics-risk-and-complianc...Ethical behavior
A-TITLE Ethical behavior
/esg/ethics-risk-and-complianc...Compliance
A-TITLE Compliance
/esg/ethics-risk-and-complianc...Human rights
A-TITLE Human rights
/esg/ethics-risk-and-complianc...Learning and engagement
A-TITLE Learning and engagement
/esg/ethics-risk-and-complianc...Integrated risk assurance
A-TITLE Integrated risk assurance
/esg/global-healthGlobal health
A-TITLE Global health
/esg/global-health/pandemic-pr...Pandemic preparedness
A-TITLE Pandemic preparedness
/esg/global-health/avoidable-b...Avoidable blindness
A-TITLE Avoidable blindness
/diseases/chagas-diseaseChagas disease
A-TITLE Chagas disease
/diseases/leprosyLeprosy
A-TITLE Leprosy
/diseases/malariaMalaria
A-TITLE Malaria
/diseases/sickle-cell-diseaseSickle cell disease (SCD)
A-TITLE Sickle cell disease (SCD)
https://www.novartisfoundation...Neues Fenster Extern Subdomain Novartis Foundation
A-TITLE Novartis Foundation
/about/inclusionTextduplikat Inclusion
A-TITLE Inclusion
/esg/indexESG index
A-TITLE ESG index
/investors/reporting-and-trans...Reporting and transparency hub
A-TITLE Reporting and transparency hub
/investors/reporting-and-trans...ESG rating performance
A-TITLE ESG rating performance
/investors/reporting-and-trans...Targets
A-TITLE Targets
/investors/reporting-and-trans...Textduplikat Patient organization funding
A-TITLE Patient organization funding
/investors/reporting-and-trans...Payments to healthcare professionals
A-TITLE Payments to healthcare professionals
/investors/reporting-and-trans...Public policy
A-TITLE Public policy
/investors/reporting-and-trans...A living wage
A-TITLE A living wage
/investors/reporting-and-trans...A safe workplace
A-TITLE A safe workplace
/investors/reporting-and-trans...Animal research
A-TITLE Animal research
/investorsInvestors
A-TITLE Investors
/investors/event-calendarEvent calendar
A-TITLE Event calendar
/investors/financial-dataFinancial data
A-TITLE Financial data
/investors/financial-data/annu...Novartis annual results
A-TITLE Novartis annual results
/investors/financial-data/quar...Novartis quarterly results
A-TITLE Novartis quarterly results
/investors/financial-data/sec-...Novartis SEC filings
A-TITLE Novartis SEC filings
/investors/financial-data/prod...Product sales
A-TITLE Product sales
/investors/financial-data/fixe...Fixed-income securities
A-TITLE Fixed-income securities
/investors/financial-data/expe...Expected currency impact
A-TITLE Expected currency impact
/investors/share-data-and-anal...Share data and analysis
A-TITLE Share data and analysis
/investors/share-data-and-anal...Share monitor
A-TITLE Share monitor
/investors/share-data-and-anal...Dividend information
A-TITLE Dividend information
/investors/share-data-and-anal...Share ownership
A-TITLE Share ownership
/investors/share-data-and-anal...Share overview
A-TITLE Share overview
/investors/share-data-and-anal...Return on investment calculator
A-TITLE Return on investment calculator
/investors/shareholder-informa...Shareholder information
A-TITLE Shareholder information
/investors/shareholder-informa...General Meetings
A-TITLE General Meetings
/investors/shareholder-informa...American Depositary Receipts (ADR)
A-TITLE American Depositary Receipts (ADR)
/investors/shareholder-informa...Share buyback
A-TITLE Share buyback
/investors/shareholder-informa...Frequently asked questions
A-TITLE Frequently asked questions
/investors/company-overviewCompany overview
A-TITLE Company overview
/investors/company-overview/co...Corporate governance
A-TITLE Corporate governance
/investors/reporting-and-trans...Textduplikat Reporting and transparency hub
A-TITLE Reporting and transparency hub
/investors/reporting-and-trans...Reporting archive
A-TITLE Reporting archive
/investors/reporting-and-trans...Textduplikat ESG rating performance
A-TITLE ESG rating performance
/news/stay-up-to-datePublications order form
A-TITLE Publications order form
https://www.novartis.com/esgTextduplikat ESG
A-TITLE ESG
https://www.novartis.com/newsNews
A-TITLE News
/news/newsroomNewsroom
A-TITLE Newsroom
/news/media-libraryMedia library
A-TITLE Media library
https://www.novartis.com/storiesStories
A-TITLE Stories
/news/stay-up-to-dateSubscribe
A-TITLE Subscribe
https://www.novartis.com/eventsEvents
A-TITLE Events
https://www.novartis.com/careersCareers
A-TITLE Careers
/careers/career-searchCareer search
A-TITLE Career search
/careers/our-business-functionsOur business functions
A-TITLE Our business functions
/careers/our-business-function...Careers in research and development
A-TITLE Careers in research and development
/careers/our-business-function...Careers in operations
A-TITLE Careers in operations
/careers/our-business-function...Careers in commercial and sales
A-TITLE Careers in commercial and sales
/careers/our-business-function...Careers in global functions
A-TITLE Careers in global functions
/careers/why-novartisWhy Novartis
A-TITLE Why Novartis
/careers/career-hubCareer hub
A-TITLE Career hub
https://novartis.willhire.co/Neues Fenster Extern Subdomain Temporary contracts
A-TITLE Temporary contracts
/careers/early-careersEarly careers
A-TITLE Early careers
/careers/early-careers/graduatesGraduates
A-TITLE Graduates
/careers/early-careers/studentsStudents
A-TITLE Students
/careers/early-careers/us-biom...US Biomedical Research internship programs
A-TITLE US Biomedical Research internship programs
/careers/early-careers/communi...Community exploration and learning lab (CELL)
A-TITLE Community exploration and learning lab (CELL)
/clinicaltrialsClinical trials
A-TITLE Clinical trials
/partneringPartnering
A-TITLE Partnering
/supplier-portalSupplier portal
A-TITLE Supplier portal
https://www.novartis.com/reportNeues Fenster Report side effects
A-TITLE Report side effects
https://www.novartis.com/contactsContacts
A-TITLE Contacts
/about/therapeutic-areasDiscover our medicines Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.
IMG-ALT Two men, seated indoors around a table, engaged in a conversation and playing chess
/research-and-developmentExplore our science Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.
IMG-ALT A female research scientist in a lab looking at a sample
https://www.novartis.com/esgLearn about our impact Creating a medicine is just the beginning of the journey. Discover how we embrace societal impact as a core business objective.
IMG-ALT Group of warm clothed women, seated outside, smiling and laughing
/events/novartis-financial-res...Learn more
A-TITLE Learn more
/news/media-releases/novartis-...Jul 17, 2025 Ad hoc release Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the company
/news/media-releases/novartis-...Jul 17, 2025 Ad hoc release Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
/news/media-releases/novartis-...Jul 08, 2025 Press release Novartis receives approval for first malaria medicine for newborn babies and young infants
/news/newsroomAll news
A-TITLE All news
https://live.novartis.com/Neues Fenster Extern Subdomain Textduplikat Learn more
A-TITLE Learn more
https://www.novartis.com/careersJoin us
A-TITLE Join us
/sites/novartis_com/files/nova...Neues Fenster Download the Integrated Report (PDF 5.0 MB)
A-TITLE Download the Integrated Report (PDF 5.0 MB)
https://www.novartis.com/aboutAbout Novartis
A-TITLE About Novartis
/healthcare-professionalsTextduplikat Healthcare professionals
A-TITLE Healthcare professionals
/patients-and-caregiversTextduplikat Patients and caregivers
A-TITLE Patients and caregivers
/research-development/novartis...Pipeline
A-TITLE Pipeline
/about/productsTextduplikat Products
A-TITLE Products
/patients-and-caregiversTextduplikat Patients and caregivers
/healthcare-professionalsTextduplikat Healthcare professionals
/research-and-developmentResearchers
https://www.novartis.com/careersJob seekers
https://www.novartis.com/newsJournalists
/investorsTextduplikat Investors
/events/novartis-financial-res...Q2 2025
/esg/accessTextduplikat Access
https://www.novartis.com/esgTextduplikat ESG
/esg/ethics-risk-and-complianc...SpeakUp
/research-development/novartis...Textduplikat Pipeline
/about/productsTextduplikat Products
/clinicaltrialsTextduplikat Clinical trials
/partneringTextduplikat Partnering
https://www.novartis.com/eventsTextduplikat Events
/about/therapeutic-areas/cardi...Textduplikat Cardiovascular, renal and metabolic
/about/therapeutic-areas/immun...Textduplikat Immunology
/about/therapeutic-areas/neuro...Textduplikat Neuroscience
/about/therapeutic-areas/oncologyTextduplikat Oncology
https://www.linkedin.com/compa...Neues Fenster Extern Subdomain A-TITLE LinkedIn
https://www.facebook.com/novartisNeues Fenster Extern Subdomain A-TITLE Facebook
https://x.com/novartisNeues Fenster Extern A-TITLE X formerly known as Twitter
https://www.instagram.com/nova...Neues Fenster Extern Subdomain A-TITLE Instagram
https://www.youtube.com/user/n...Neues Fenster Extern Subdomain A-TITLE Youtube
/terms-useTerms of use
https://www.novartis.com/privacyPrivacy
https://www.novartis.com/Anchor Cookie settings
https://www.novartis.com/contactsTextduplikat Contacts
/about/locationsLocations
/sitemap.xmlSite map
/open-sourceOpen source
/accessibilityWeb accessibility
/novartis-directoryNovartis Site Directory
A-TITLE Novartis Site Directory

Serverkonfiguration

HTTP-Weiterleitungen
(Extrem wichtig)
Die Seite leitet weiter auf "https://www.novartis.com/"
HTTP-Header
(Wichtig)
Es wird kein X-Powered HTTP-Header mitgesendet.
Der Webserver überträgt die Webseite (HTML) komprimiert.
Performance
(Wenig wichtig)
Die Antwortzeit der HTML-Seite ist mit 0,38 Sekunden unter der Zielmarke von 0,40 Sekunden.
Die Dateigröße des HTML-Dokuments ist mit 203 kB in Ordnung.

HTTP-Header

NameWert
dateSat, 09 Aug 2025 05:54:11 GMT
content-typetext/html; charset=UTF-8
content-encodingbr
cf-ray96c4ff528ccadd47-CDG
cf-cache-statusHIT
age3204
cache-controlmax-age=60, public, s-maxage=2628000, stale-if-error=180, stale-while-revalidate=180
content-languageen
expiresSun, 19 Nov 1978 05:00:00 GMT
last-modifiedSat, 09 Aug 2025 01:48:38 GMT
strict-transport-securitymax-age=31536000; includeSubDomains
varyCookie,Accept-Encoding
viavarnish
content-security-policy-report-onlyscript-src 'self' 'unsafe-inline' 'unsafe-eval' https://unpkg.com https://acsbapp.com https://snap.licdn.com https://sc-static.net https://tr.snapchat.com https://maps.googleapis.com https://static.ads-twitter.com https://analytics.twitter.com https://connect.facebook.net https://cdn.cookielaw.org https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://cdnsecakmi.kaltura.com https://cdnapisec.kaltura.com http://cdnapi.kaltura.com https://cfvod.kaltura.com https://www.google-analytics.com https://cdn.jsdelivr.net https://script.crazyegg.com https://static.cloudflareinsights.com https://www.google.com https://www.gstatic.com https://bam.nr-data.net https://hm.baidu.com/hm.js https://www.clarity.ms https://www.googleadservices.com blob: https://vjs.zencdn.net/5.0/video.min.js; object-src 'self' 'unsafe-inline' 'unsafe-eval' https: data; style-src 'self' 'unsafe-inline' 'unsafe-eval' https://cdn.cookielaw.org https://acsbapp.com https://sc-static.net https://tr.snapchat.com https://maps.googleapis.com https://fonts.googleapis.com https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://script.crazyegg.com https://static.cloudflareinsights.com https://cdnapisec.kaltura.com https://cfvod.kaltura.com https://vjs.zencdn.net/5.0/video-js.min.css; frame-ancestors 'self'; report-uri /report-csp-violation
x-ah-environmentprod
x-cacheHIT
x-cache-hits157
x-content-type-optionsnosniff
x-dns-prefetch-controloff
x-frame-optionsSAMEORIGIN
x-request-idv-f894d8f2-74c2-11f0-b72a-1be4259af463
x-xss-protection1; mode=block
server-timingcfCacheStatus;desc="HIT"
servercloudflare
statuscode200
http_versionHTTP/2

Externe Faktoren

Die Seite wird von Wikipedia verlinkt.
Die Seite ist exzellent von anderen Webseiten verlinkt.
Die Seite hat Backlinks von 5.267 verweisenden Domains.
Die Seite hat insgesamt 377.278 Backlinks.
Die Seite hat Backlinks von 3.748 verschiedenen IP Adressen.

Robots.txt

#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used:    http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/robotstxt.html

User-agent: *
# CSS, JS, Images
Allow: /core/*.css$
Allow: /core/*.css?
Allow: /core/*.js$
Allow: /core/*.js?
Allow: /core/*.gif
Allow: /core/*.jpg
Allow: /core/*.jpeg
Allow: /core/*.png
Allow: /core/*.svg
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /profiles/*.svg
# Directories
Disallow: /core/
Disallow: /profiles/
# Files

Disallow: /web.config
# Paths (clean URLs)

Disallow: /comment/reply/
Disallow: /filter/tips

Disallow: /search/




# Paths (no clean URLs)

Disallow: /index.php/comment/reply/
Disallow: /index.php/filter/tips

Disallow: /index.php/search/




Disallow: /*printable
Disallow: /de-de/sites/novartis_de/files/*FAQ*
Disallow: /de-de/sites/novartis_de/files/*RMP*
Disallow: /de-de/sites/novartis_de/files/*FAQ*
Disallow: /de-de/sites/novartis_de/files/*RMP*
Disallow: /*/spc/*FAQ*
Disallow: /*/spc/*RMP*
Disallow: /*FAQ*
Disallow: /*RMP*

User-agent: GPTBot
Crawl-delay: 2

User-agent: bingbot
Crawl-delay: 2

User-agent: GoogleOther
Crawl-delay: 2

Suchvorschau

www.novartis.com
Novartis
Working together, we can reimagine medicine to improve and extend people’s lives.

Wichtigste Suchbegriffe

Folgende Keywords wurden erkannt. Überprüfe die Optimierung dieser Keywords für Deine Seite.

KeywordErgebnisPrüfen
Novartis66%Check
medicine66%Check
reimagine medicine58%Check
People52%Check
Working50%Check
Live50%Check
extend people49%Check
Novartis Foundation48%Check
Q2 202548%Check
lives46%Check

Analysiere novartis.com jetzt automatisch und vollständig mit allen Unterseiten!

Jetzt kostenlos testen
Garantiert keine Kosten während der Testphase.

Cookie Einstellungen

Wir verwenden Cookies, damit unsere Website funktioniert und auch für Analyse- und Werbezwecke. Du kannst optionale Cookies selbstverständlich auch deaktivieren, siehe die folgenden Links für weitere Informationen.

Diese Cookies werden für grundlegende Websitefunktionen benötigt.

Damit wir besser verstehen, wie Besucher unsere Website nutzen.

Damit wir für Dich passgenaue Angebote bereitstellen können.